Drug-resistant or "intractable" epilepsy presents a major challenge for physicians, epilepsy associations and researchers. Dr. Leppik discusses the evaluation of patients who may be intractable, the nature of intractable epilepsy and the factors which contribute to intractability.
|Original language||English (US)|
|Number of pages||7|
|Journal||Advances in experimental medicine and biology|
|State||Published - May 28 2002|